21-46411651-G-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_006031.6(PCNT):c.5578G>T(p.Glu1860*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,612,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_006031.6 stop_gained
Scores
Clinical Significance
Conservation
Publications
- microcephalic osteodysplastic primordial dwarfism type IIInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Moyamoya diseaseInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006031.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PCNT | NM_006031.6 | MANE Select | c.5578G>T | p.Glu1860* | stop_gained | Exon 28 of 47 | NP_006022.3 | ||
| PCNT | NM_001315529.2 | c.5224G>T | p.Glu1742* | stop_gained | Exon 28 of 47 | NP_001302458.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PCNT | ENST00000359568.10 | TSL:1 MANE Select | c.5578G>T | p.Glu1860* | stop_gained | Exon 28 of 47 | ENSP00000352572.5 | ||
| PCNT | ENST00000480896.5 | TSL:1 | c.5224G>T | p.Glu1742* | stop_gained | Exon 28 of 47 | ENSP00000511989.1 | ||
| PCNT | ENST00000695558.1 | c.5611G>T | p.Glu1871* | stop_gained | Exon 29 of 48 | ENSP00000512015.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152222Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.00000810 AC: 2AN: 246834 AF XY: 0.00000744 show subpopulations
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1460726Hom.: 0 Cov.: 34 AF XY: 0.00000688 AC XY: 5AN XY: 726708 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152222Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74370 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Microcephalic osteodysplastic primordial dwarfism type II Pathogenic:2
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Glu1860*) in the PCNT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PCNT are known to be pathogenic (PMID: 18174396, 22821869). This variant is present in population databases (rs369195346, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with microcephalic osteodysplastic primordial dwarfism type 2 (MOPD2) (PMID: 19643772). ClinVar contains an entry for this variant (Variation ID: 159621). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at